# Ming‐Hui Zhao

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ming-hui-zhao/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,986 |
| Field | Vasculitis and related conditions |
| h-index | 80 |
| i10-index | 419 |
| Last Known Institution | Ministry of Education of the People's Republic of China |
| OpenAlex ID | https://openalex.org/A5008236609 |
| ORCID iD | 0000-0003-3340-3108 |
| Works | 781 |

## Researcher papers

Showing 12 of 16.

- [Lupus nephritis](https://scholariq.org/papers/lupus-nephritis/)
- [Trends in Chronic Kidney Disease in China](https://scholariq.org/papers/trends-in-chronic-kidney-disease-in-china/)
- [Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-clinical-outcomes-in-patients-with-iga/)
- [Acute kidney injury in China: a cross-sectional survey](https://scholariq.org/papers/acute-kidney-injury-in-china-a-cross-sectional-survey/)
- [Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis](https://scholariq.org/papers/revised-2017-international-consensus-on-testing-of-ancas-in-granulomatosis-with/)
- [Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-decline-in-kidney-function-or-kidney/)
- [Redefining lupus nephritis: clinical implications of pathophysiologic subtypes](https://scholariq.org/papers/redefining-lupus-nephritis-clinical-implications-of-pathophysiologic-subtypes/)
- [Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis](https://scholariq.org/papers/serum-potassium-and-adverse-outcomes-across-the-range-of-kidney-function-a-ckd/)
- [Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey](https://scholariq.org/papers/status-of-care-for-end-stage-kidney-disease-in-countries-and-regions-worldwide/)
- [Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody–associated vasculitis](https://scholariq.org/papers/circulating-complement-activation-in-patients-with-anti-neutrophil-cytoplasmic/)
- [Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system](https://scholariq.org/papers/tubulointerstitial-lesions-of-patients-with-lupus-nephritis-classified-by-the/)
- [Complement Activation Is Involved in Renal Damage in Human Antineutrophil Cytoplasmic Autoantibody Associated Pauci-Immune Vasculitis](https://scholariq.org/papers/complement-activation-is-involved-in-renal-damage-in-human-antineutrophil/)

## Researcher topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Researcher university

- [Ministry of Education of the People's Republic of China](https://scholariq.org/institutions/ministry-of-education-of-the-people-s-republic-of-china/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.